As part of the May issue, the European Respiratory Journal presents the latest in its series of podcasts. Deputy chief editor James Chalmers interviews Marc Humbert (Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, and AP-HP, Service de Pneumologie, Hôpital Bicêtre, Le Kremlin-Bicêtre, and INSERM UMR_S 999, Hôpital Marie Lannelongue, Le Plessis Robinson, France) about omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count.
Supplementary Material
Subscribe to the ERJ Podcast via iTunes, SoundCloud or RSS
Download the May podcast May_2018
- Copyright ©ERS 2018